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Summary.-Although many carcinogens are mutagens, there is no direct evidence
that the cancer-cell phenotype is the result of gene mutation. Transplantation experi-
ments have strongly indicated that malignant cells can arise or revert to the normal
phenotype in the absence of mutation. It is suggested that damage to DNA followed
by repair triggers the epigenetic changes in gene expression which are responsible
for malignancy. We previously proposed that methylation of specific DNA sequences
adjacent to structural genes determines whether or not transcription will occur.
Specific methylases are required for the switching on of genes and for the stable
maintenance of the methylated state, which provides a basis for the control of gene
expression in differentiated cells. It is now seen that damage to DNA followed by
repair, just before or just after DNA replication, can lead to the loss of methyl groups.
This can induce a switch in gene activity which is heritable, but potentially reversible.
The known large difference in the probability of malignant transformation in cells of
rodents and large mammals is hard to explain if mutation is responsible. On the other
hand, this new theory provides an explanation for this difference, since the probability
of epigenetic changes in gene activity will depend on the activity of methylating
enzymes and the rate of excision repair. The theory is supported by the evidence that
excision repair is more efficient in cultured fibroblasts from large long-lived animals
than from small short-lived ones.
A WIDE VARIETY of carcinogens has
been shown to be mutagenic, especially in
the test system developed by Ames and his
collaborators (Ames et al., 1973; McCann
et al., 1975; McCann & Ames, 1976). For
this and other reasons a convincing case
can be made for the theory that the pheno-
type of the malignant cell is the conse-
quence of one or more heritable gene or
chromosome mutations (for a review see
Cairns, 1978). Nevertheless, there are
several well established observations which
are not easily compatible with this theory.
Peto (1977) has pointed out that the
probability of origin of a proliferating
cancer cell in a small short-lived animal,
such as a mouse, is enormously higher
(perhaps by a factor as great as 106-109)
than the same event in a larger long-lived
animal, such as man. This difference is
seen also in cultured cells: it is well known
that diploid rodent cells frequently trans-
form spontaneously into a permanent line
ofmalignant cells, whereas the same spon-
taneous transformation of human cells is
not observed in vitro. On the other hand
the frequency ofparticular gene mutations
in cultured rodent and human cells does
not appear to be very different, and this is
probably also true forgerm-line mutations.
Huberman et al. (1976) compared the
frequency of mutant and transformed
clones in hamster cells and found that the
latter were about 20 times more frequent.
In contrast, transformation must be much
rarer in human cells than mutation,
whether or not mutagenic treatment is
applied. These results indicate that trans-
formation in vivo or in vitro may not be
due to heritable mutations.
* This paper is in large part based on the i(leas ofmy colleague J. E. Pugh. He first discussed thetheory at
a meeting ofthe Genetical Society of Great Britain in November 1977 (see Pugh & Holli(lay, 1978), but (did
not cotesis(1i that its puiblication in full was justifie(l.R. HOLLIDAY
According to the mutation theory of
cancer, the heritable anomalies affecting
gene expression and differentiation should
not readily be reversible or reprogram-
mable, and yet in certain cases this is
demonstrably untrue of cancer cells.
Mouse embryo cells transplanted to the
kidney capsule of adults often give rise to
teratocarcinomas which form benign tu-
mours in females, but can be malignant in
males. Teratocarcinoma cells are pluri-
potent and give rise to a variety of differ-
entiated cell types in vivo as well as in
culture. When genetically marked tera-
toma cells are injected into mouse blasto-
cysts they can be recovered in a variety
of tissues in the fully developed animals
(Mintz & Illmensee, 1975; Papaioannou
et al., 1975). These cell-transplantation
experiments do not prove that the genetic
material ofthesetumour cellsis completely
normal, but they certainly show that the
tumour-cell phenotype can be reversed
when the teratoma cell finds itself in a
cellular environment where reprogram-
ming can occur.
Another probable example of a non-
mutational origin of cancer comes from
transplantation experiments with mouse
ovarian cells. If one ovary is removed and
the other is transplanted to the spleen,
the ovarian cells may start to proliferate
and then become cancerous (Furth, 1947).
It has also been demonstrated that nuclei
from the Lucke adenocarcinoma of the
frog can be used to reconstitute anucleate
eggs, which are sometimes capable of
giving rise to normal tadpoles (King & Di
Berardino, 1965; McKinnell et al., 1969).
The view that cancer is essentially a
developmental aberration or a disease of
differentiation is, of course, not a new one
(see, for example, Markert, 1968). It is well
known that tumour cells often gain new
surface antigens or produce proteins or
tRNAs which are normally present only
in embryonic cells (see Coggin & Anderson,
1974; Medawar, 1977). In principle, gene
mutation could produce multiple or abnor-
mal changes in gene expression; however,
for the reasons just summarized, a strong
case can be made for an epigenetic or non-
mutational origin of cancer. The problem
is then to explain how the initial damage to
DNA by carcinogens can lead to heritable
changes in gene expression, in the absence
of mutation. I shall suggest that the
accurate repair of DNA lesions may have
the side effect of causing these epigenetic
changes in somatic cells.
Modification ofDNA during development
Possible mechanisms for the temporal
control of gene activity during develop-
ment which attempt to account both for
the segregation of different cell types and
the overall stability of the differentiated
state have been proposed (Holliday &
Pugh, 1975). These and other authors have
proposed that control sequences adjacent
to structural genes mayexistin alternative
states (Scarano, 1971; Venner & Reinert,
1973; Kauffman, 1973). In our hypothesis,
these states depend onthe specific enzymic
modification of bases in these sequences,
such that the modified form allows binding
of a transcribing RNA polymerase, where-
as the unmodified form does not (or vice
versa). Although such modifications could
in principle involve actual changes in base
sequences we (Holliday & Pugh, 1975),
were also able to explain how the specific
methylation of bases such as adenine or
cytosine could provide epigenetic switches
in gene activity. Recently it has been
shown that the differentiation of Friend
erythroleukaemic cells in vitro is related to
the extent of DNA methylation (Christ-
man et al., 1977). One possible switch
mechanism is illustrated in Fig. 1. It
depends on a transient setting or switch
enzyme which recognizes a specific con-
trolling sequence and modifies one strand
of DNA just before DNA synthesis. Sub-
sequently a second maintenance enzyme
recognizes the half-methylated site after
replication and adds a methyl group at the
appropriate position on the other strand.
The maintenance enzyme does not act on
non-methylated DNA. Once a control
sequence is modified it will be completely
stable through subsequent cell division,
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FIG. 1.-The control ofgene activity by DNA
methylation. A palindromic controlling se-
quence is adjacent to a structural gene. If
the sequence is methylated on both DNA
strands, transcription occurs; if it is not
methylated, thegeneisswitchedoff,perhaps
because a repressor binds only to the non-
methylated sequence. The switch in gene
activity depends on an enzyme which
recognizes halfthe palindrome andan adja-
cent sequence and methylates one strand.
It is active just before DNA synthesis and
is inhibited or degraded after synthesis. The
half-methylated palindrome is a substrate
for a second maintenance methylase, which
does not recognize non-methylated DNA.
In the presence of maintenance enzyme,
gene activity is stable through cell division.
(Note that the elimination of the switch
methylase may be due to the activity of a
structural genewhichithasturnedon. Ifthe
switch methylase is not transient, a stem-
line situation may occur in which methyla-
ted differentiated cells are continually
formed from dividing undifferentiated cells,
as described by Holliday & Pugh, 1976.)
provided the maintenance enzyme is
present and always modifies DNA before
the next S phase. These modifications
allow transcription of genes which were
previously inactive and this may in turn
trigger further specific methylating en-
zymes. We supposed that many different
specific switching or setting methy-
lases exist, and that their appearance
in development may often be tran-
sient. On the other hand, maintenance
methylases need be only few in number,
always present, and less sequence-specific.
We also described mechanisms for count-
ing cell divisions (developmental clocks)
based on the processive methylation of
tandem arrays of controlling sequences.
All these changes in methylation are
potentiallyreversible. Indevelopmentfrom
a fertilized egg the methyl groups may be
removed by a relatively nonspecific en-
zyme;alternatively, theabsenceofmethyl-
ases will simply lead to the dilution out of
methyl groups during the early-cleavage
divisions.
In summary, we proposed that the pro-
gramme for development depends on a
temporal sequence of epigenetic changes,
in which cell division and segregation of
gene activities in different cell lineages are
essential components. The various succes-
sive segregations of gene activity during
development mean that cells become pro-
gressively less related to each other in
biochemical terms as they move down
their specific developmental pathways. In
particular, they will have a different
pattern ofspecific DNA modifications (and
modifying enzymes) which are directly
responsible for controlling gene activity.
It shouldbenotedthatifone differentiated
cell has proteins A, B, C and D present
and another E, F, G and H, then in a
normal organism there might be no cells
with, for instance, A, B, G or H proteins.
It is possible that such combinations are
incompatible or "forbidden", since they
will give rise to aberrant gene expression
and the breakdown of normal cellular
functions.
Repair ofDNA damage
Considerable information is now avail-
able about the various pathways of DNA
repair (for recent reviews, see Hanawalt
515R. HOLLIDAY
A
CH3
.
CH3
B
C~H,
C
CH3
DNA is damaged immediately in front of
the replication fork. Excision of the
damaged base(s) and repair synthesis,
immediately followed by normal DNA
synthesis, can lead to the formation of a
short region of DNA in which neither
strand carries a methyl group. This is no
longer a substrate for the maintenance
enzyme. A similar situation occurs when
newly synthesized DNA, which is not yet
methylated, is damaged by a carcinogen
(Fig. 3). The parental strand is excised
along with the crucial methylated base,
and again a region of DNA is produced
without any modified bases. In both cases
I assume that there is some delay in the
methylation of newly synthesized DNA,
as experimental results indicate (Adams,
1974).
In bacteria, it is known that damage to
a DNA template prevents DNA poly-
merization and leads to gaps opposite the
D
CH3
CH,
FIG. 2. Excision repair of damage to DNA
immediately in front of a replication fork.
Iftheexcisionisinitiated close to amethyla-
ted controlling sequence (A), a methylated
base is stripped away (B) and repair syn-
thesis will insert a non-methylated base (C).
Replication ofthisregionbeforemethylation
can occur gives rise to one non-methylated
DNA duplex, which is not substrate for the
maintenance methylase, and one half-
methylated duplex which will become
methylated (D).
et al., 1978). One ofthe best understood is
excision repair. When one strand of DNA
is damaged, for instance, by the produc-
tion of a pyrimidine dimer by UV light,
the other strand acts as a template for the
resynthesis of normal DNA, following the
excision of the abnormal and some adja-
cent bases. The basis of the theory is that
repair events can lead to the formation of
non-methylated DNA in cells which are
dividing andthereby alter geneexpression.
Consider first the case (Fig. 2), in which
A CH3
CH3
B
CH3
CH3
C
CH3
CH3
FIG. 3. Repair of damage to DNA, close to
a controlling sequence immediately after
replication (A). Excisionbefore thedaughter
strand has been methylated (B), followed
by repair synthesis, gives rise to a non-
methylated duplex (C) which is not a sub-
strate for the maintenance methylase.
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methylated controlling sequence,
tion of the recombination event (a
to the model of Meselson & Raddir
can give rise to a doubly methylate(
ter strand and a non-methylatec
(D, E). It is assumed that the fillix
gap by recombination allows sul
excision repair of the initial lesi
recombination event shown i
reciprocal, but DNA strand isom(
(Sobell, 1974) can produce a rE
crossover, as described by Hollida3
damaged base(s). Such gaps are normally
filled by a recombination repair mechan-
ism (Rupp et al., 1971). In mammalian
cells the evidence is conflicting. Gap-filling
can occur by a mechanism which does not
W\ y~j require recombination (Lehmann, 1972)
but otherexperiments indicatetheinvolve-
ment of recombination (Meneghini &
Hanawalt, 1976; Meneghini and Menck,
1978). It is well known that sister-strand
recombination is a frequent event after
treatment of cells with DNA-damaging
agents (Perry & Evans, 1975). It has been
shown that this process leads to the for-
3 mation of hybrid DNA in which poly-
nucleotide chains exchange pairing part-
ners (Rommelaere & Miller-Faures, 1975;
- Moore & Holliday, 1976).
> --- Of the several possible recombination
repair configurations one is illustrated in
Fig. 4, which is based on the model of
M Meselson & Radding (1975). The transfer
of a parental strand from one daughter
molecule to the other leads to the forma-
tion of hybrid DNA containing methyl
groups on both strands, and damage in
one. This damage could then be repaired ~ by excision, with preservation of the
modified controlling sequence. On the
other hand the sister DNA molecule will
lose its methyl groups if hybrid DNA has
been formed before modification of the
_ new DNA strand (Fig. 4).
The configuration shown in Fig. 4 is
an example of non-reciprocal recombina-
tion. However, DNA-strand isomeration
can generate a reciprocal crossover event
Lesions in between daughter chromatids (see Holli-
gapi(n) day, 1964; Sigal & Alberts, 1972; Sobell,
*f hybrid 1974; Potter & Dressler, 1976). Such eludes a cross-overs would be expressed as sister- comple- strand exchanges in mammalian cells tccording ng, 1976) treated with agents damaging DNA.
d daugh- Tumours arise predominantly in tissues
ng of the containing dividing cells, and rarely if at bsequent all in cells which do not divide, such as
ion. The neurones or muscle (see Cairns, 1978). is non-
erization Cultured cells are particularly susceptible eciprocal to transformation by chemical carcinogens
r (1964). in the S phase ofthe cell cycle (Marquardt,
1974). These observations are consistent
0
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with the model, since the loss of methyl
groups by repair requires chromosome
replication. It is, however, possible that
non-dividing terminally differentiated cells
no longer have maintenance methylases.
In this case excision repair of damage to
DNA, followed some time later by the
stimulation of cell division, would lead to
the formation of non-modified controlling
sequences. Alternatively, if both strands
are damaged at nearby sites at different
times, successive excision repair events
will yield non-methylated controlling se-
quences, provided no maintenance methy-
lase is present. Another possibility is that
carcinogens alter DNA in such a way that
it is no longer a substrate for methylating
enzymes. Experimental evidence that this
can occur has recently been obtained by
Salas et al. (1979).
Production of non-methylated control-
ling sequences would not by itself neces-
sarily damage the cell. It may for instance
simply lead to the turning off of dispens-
able genes. Controlling sequences adjacent
to the structural genes for specific methyl-
ating enzymes are likely to be the sig-
nificant targets, since these could lead to
pleiotropic effects on gene expression. The
cell may be triggered to move down a new
developmentalpathwaywhichisabnormal,
including perhaps the activation of de-
velopmental clocks specifying several divi-
sions before a particular gene is expressed
or turned off. Thus the general model
predicts that malignant transformation
usually requires cell proliferation and that
the ultimate phenotype may be due to
the loss of some specialized function and
the appearance of proteins which are
usually present either at an earlier stage in
development or in a different tissue.
Protection against carcinogenesis
I have already referred to the very
different probabilities of carcinogenesis in
small short-lived animals and large long-
lived ones. If the theory is correct, there
are essentially two ways by which an
organism could protect itself against
carcinogenesis. The likelihood of losing
methyl groups following repair is directly
related to the speed of methylation. Thus
greater maintenance-methylase activity
will reduce the likelihood of abnormal
epigenetic switches in gene activity. The
rate at which excision repair occurs is also
important. For any given genetic locus
which is methylated there will be a
"sensitive period" during the S phase of
the cell cycle. This will extend from just
before to just after the genetic replication
of that locus, and it need only be a very
small fraction of the total S phase. If
excision repair is very rapid and is imme-
diately followed by methylation, the sensi-
tive period before DNA synthesis becomes
correspondingly shorter. On the other
hand, ifexcisionrepairissloworinefficient,
there is an increased likelihood ofthe DNA
replicationforkencounteringanunrepaired
lesion. This may produce the situation
shown in Fig. 4. The likelihood of losing
methyl groups then depends on the
probability offorming hybrid DNA during
post-replication repair, relative to the
rate of methylation of newly synthesized
Pre-DNA Replication
>-A
Ci,o
i ()cJ
Post DNA Replication
A; B
z
o _%
=r
v) -:S
I_.
0
Sensitive
period
FIG. 5.-The sensitive window or period
before and after DNA replication of a par-
ticular controlling sequence (A, B). DNA
damage before replication can be repaired
by excision repair (A). The slower this re-
pair, the more likely it is that post-replica-
tion repair will take place (B). I assume
that some post-replication repair involves
recombination as shown in Fig. 4. If DNA
methylation is constant, the sensitive
window in the cell cycle decreases with
increasing efficiency of excision repair.
I/
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DNA (Fig. 4B, C). The way the efficiency
of excision repair may affect the sensitive
period is illustrated diagrammatically in
Fig. 5.
Given a constant methylation activity,
it may well be that a high ratio ofexcision
to recombination repair will be less
hazardous with regard to abnormal
changes in gene expression than a low
ratio. In general, we might therefore
expect excision to be the preferred path-
way in man and other large mammals.
This is in agreement with the observations
ofHart & Setlow (1974), who showed that
there is a clearpositive correlation between
longevity (which is also related to body
size), and the amount of excision repair
in UV-irradiated cultured fibroblasts from
a variety ofmammals. In man, the disease
conferring sensitivity to sunlight, xero-
derma pigmentosum, is known to block
excision repair of pyrimidine dimers
(Cleaver & Bootsma, 1975). It has been
recently shown that these cells have more
induced recombination (sister-strand ex-
change) after UV treatment than normal
cells (deWeerdKastelein etal., 1977). Thus
pyrimidine dimers which would normally
be removed by excision are instead dealt
with by recombination repair, and this
may explain the greatly increased inci-
dence of skin tumours in these indivi-
duals.
Many chemical carcinogens alkylate
guanine in DNA (for reviews see Pegg
1977; Lawley, 1979). Roth and Rajewsky
(1974a, b) have shown that there is a
relationship between tumour formation
and the persistence of 06-ethylguanine in
the DNA of dividing cells. Tissues such as
liver, which rapidly remove 06-ethyl-
guanine from their DNA, are refractory
to carcinogenesis by ethylnitrosourea,
whereas those which retain the altered
base much longer in their DNA, such as
foetal brain, do develop tumours. This
provides evidence for a mutational origin
of cancer, since guanine alkylated at the
06 position is mutagenic (Loveless, 1969;
Lawley & Martin, 1975). However, the
results are also consistent with this model,
since efficient excision repair ofthe alkyla-
ted base will be less likely to cause the
loss of methyl groups than replication of
the lesion followed by recombination.
Effects of ethionine, promotors and bromo-
deoxyuridine
There is at least one carcinogen, ethio-
nine, which would not be expected to alter
the structure of DNA in any way. Ethio-
nine is an analogue of methionine and its
carcinogenic activity is restricted to liver
tissue (Farber, 1963). It canbemetabolized
in liver to replace the normal amino acid
in S-adenosyl methionine. S-adenosyl-
ethionine is a poor substrate for known
methylating enzymes, since the normal
process of DNA methylation is impaired
(Swann et al., 1975). It is, however, also
possible that ethyl groups could be
donated to DNA (Swann et al., 1971) and
these could inhibit the maintenance en-
zyme. The theory I have outlined can thus
explain the carcinogenic activity of ethio-
nine, because its presence in dividing cells
could lead to the loss of methylation in
controlling sequences. Recentlyit has been
shown that ethionine can stimulate the
in vitro differentiation of Friend cells
(Christman et at., 1977) and that this is
related to a reduction in DNA methyla-
tion.
In many instances it has been shown
that the effect of carcinogens is weak or
absent unless promoting agents, such as
phorbol esters, are subsequently applied.
Moreover, the initial effect of the carcino-
gen is "remembered", since promotors are
almost as effective when used many
months after carcinogenic treatment as
they are when used immediately (for
a review see Berenblum, 1974). There is
evidence that promotors can block ter-
minal differentiation of mouse erythro-
leukaemia cells and chick myoblast cul-
tures (Cohen et al., 1977; Rovera et al.,
1977; Yamasaki et al., 1977). If their
action is related to the control of gene
expression, they may well interact with
cells in which abnormal switches in
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gene activity have already occurred. In
particular, by preventing terminal differ-
entiation, they might allow the continued
proliferation ofcancerous or pre-cancerous
cells.
Bromodeoxyuridine (BUdR) also blocks
cell differentiation in a variety of situa-
tions (for a review see Rutter et al., 1973).
Recently it has been found that human
foetal lung fibroblasts grown in the
presence of low levels of BUdR for many
cell generations assume many of the pro-
perties of transformed cells, including loss
of contact inhibition, growth in soft agar
or low levels of serum (L. I. Huschtscha &
R. Holliday, unpublished results). This
phenotype persists when BUdR is re-
moved. It is striking that all attempts to
transform human foetal fibroblasts with
potent mutagens have failed, whereas an
agent known to effect cell differentiation
may apparently induce transformation.
Kinsella & Radman (1978) haverecently
obtained evidence that promotors induce
sister-strand recombination in mammalian
cells. They suggest that their promoting
action is due to the expression ofrecessive
mutations by mitotic crossing over (see
also Peto et al., 1975). It is possible that
mitotic crossing over between homologues
plays a role in the mechanism we have
proposed, since the switching off of a
gene could be a recessive epigenetic event
which must become homozygous to affect
the phenotype. However, this recombina-
tion between homologues seems to be
extremely rare or absent in mammalian
somatic cells (Gladstone et al., 1976;
Tarrant & Holliday, 1977; Rosenstraus &
Chasin, 1978).
CONCLUSIONS
Holliday & Pugh (1975) have pre-
viously proposed a theory of development
which attempted to provide a molecular
basis for the segregation of gene activities
during development and the very great
stability ofthe differentiated state. It was
suggested that specific controlling se-
quences adjacent to structural genes are
modified by specific methylating enzymes,
and that the presence or absence of such
modification constitutes the "on" and
"'off" signals for transcription of the
adjacent structural genes. Once the switch
is set, the presence or absence of methyla-
tion in different cells is stably maintained,
or heritable. This programming process,
which is assumed to occur throughout the
whole of development of complex organ-
isms, is reversed at oogenesis or during the
early cleavage divisions by the removal or
dilution out of all methyl groups. I have
now shown that damage to DNA which is
susceptible to repair mechanisms could
lead to the loss of specific DNA methyla-
tions, which in turn would lead to changes
in gene expression. If the gene concerned
is itself involved in setting the pattern of
modified bases in differentiated cells,
one might expect multiple effects on gene
activity, including the appearance of
embryonic antigens. These changes could
occur over several cell generations, but
the final phenotype of the cancer cells
might be relatively stable, with the reten-
tion of some of the specialized properties
ofthe cell type from which it was derived.
In outlining the theory, I have avoided
discussion of viral oncogenesis. The inte-
gration of a viral genome could clearly
change gene activity directly, as in muta-
tion, or indirectly, as in this DNA-
modification hypothesis. I am not aware
of any studies on tumour viruses which
either specifically support or are contrary
to our model. Nor is it possible to make
specific predictions about the malignancy
of hybrids obtained by fusing malignant
cells with non-malignant ones, since epi-
genetic changes could be either dominant
or recessive. It might, however, be expec-
ted that the fusion of 2 different types
of differentiated diploid cell to form a
hybrid would sometimes have pleiotropic
consequences comparable to those we have
been discussing. This stems from the point
raised earlier, namely, that developmental
pathways diverge from each other and
that specialized differentiated cells contain
gene products (especially specific methyl-
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ases) which are never normally in direct
contact with those from other specialized
cell types. Therefore abnormalities in gene
expression mightbe expected. Itis remark-
able that in all hybridization experiments
so far reported, either one of the parents
is already a transformed line, or both
parents are fibroblasts. The prediction
that the fusion of two normal cells from
different tissues might sometimes lead to
a transformed phenotype has therefore
not yet been experimentally tested. The
theory also predicts that the very great
difference in the frequency of carcino-
genesis in rodents and large long-lived
animals (Peto, 1977) is due to the activity
of specific methylating enzymes and the
efficiency of excision repair, rather than
to differences in mutation frequency. I
feel that the case for a mutational origin
of cancer has often been overstated, per-
haps because it has been too readily
assumed that DNA damage is equivalent
to mutation. Nevertheless, it is appro-
priate to conclude by stating that none
of the above suggestions exclude the
possibility that some tumours are the
result of gene mutation.
I thank R. Peto, H. J. F. Cairns, P. D. Lawley
and M. H. Green for helpful comments.
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